HONG KONG--(Marketwire - Jun 7, 2012) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Sanofi SA (ADR) (NYSE: [ SNY ]) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE: [ TEVA ]). Gain market insight with full analysis and research downloads available at [ www.BrightonMarkets.com/index.php?coa=SNY&cob=TEVA ].

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Brighton Markets is releasing new coverage on Sanofi SA (ADR) for its current position within the healthcare industry. Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. The full research report on Sanofi SA (ADR) (NYSE: [ SNY ]) is available here: [ www.BrightonMarkets.com/index.php?coa=SNY ].

Brighton Markets has released research on Teva Pharmaceutical Industries Ltd (ADR) for its changing role within the healthcare industry. Teva Pharmaceutical Industries Ltd (Teva) is a global pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment categories. The Company has a pharmaceutical business, whose principal products include Copaxone and Azilect. The full research report on Teva Pharmaceutical Industries Ltd (ADR) (NYSE: [ TEVA ]) is available here: [ www.BrightonMarkets.com/index.php?cob=TEVA ].

About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.